Boryung

Boryung company information, Employees & Contact Information

Explore related pages

Related company profiles:

Boryung is a healthcare investment company founded in 1957 and headquartered in Seoul, South Korea. Following the company’s mission to become an indispensable contributor to human health, we have expanded our business portfolio to the space healthcare industry. Recognizing space as a new growth realm, we acknowledge the increasing number of individuals anticipated to embark on extended space missions, highlighting the importance of ensuring human survival in the hostile space environment. Hence, Boryung believes there will be substantial opportunities to foster new technologies and meet the emerging needs in this field. Connect with us: humansinspaceoffical.com instagram.com/humansinspace_official/ facebook.com/humansinspace.official twitter.com/humansinspace_ youtube.com/@Humans_In_Space

Company Details

Employees
106
Founded
-
Address
북촌로 104, 서울특별시,korea, Republic Of
Industry
Investment Management
NAICS
Other Financial Investment Activities
Portfolio Management
All Other Financial Investment Activities
Trust, Fiduciary, and Custody Activities
Miscellaneous Financial Investment Activities
Keywords
San Francisco.
HQ
서울특별시
Looking for a particular Boryung employee's phone or email?

Boryung Questions

News

Boryung to hold space station art showcase - The Korea Times

Boryung to hold space station art showcase The Korea Times

Boryung CEO Kim Jung-kyun (photo) dismissed rumors of a recent sale of the pharmaceutical industry a.. - 매일경제

Boryung CEO Kim Jung-kyun (photo) dismissed rumors of a recent sale of the pharmaceutical industry a.. 매일경제

Boryung Expands Investment in Space Healthcare Business - Businesskorea

Boryung Expands Investment in Space Healthcare Business Businesskorea

Boryung Consumer Healthcare Launches 'The Black' Black Goat Extract with Red Ginseng - 아시아경제

Boryung Consumer Healthcare Launches 'The Black' Black Goat Extract with Red Ginseng 아시아경제

Boryung and MirimGENE to co-develop innovative new drugs - koreabiomed.com

Boryung and MirimGENE to co-develop innovative new drugs koreabiomed.com

SN BioScience and Boryung Announce the Licensing Agreement on Generic Version of Abraxane - PR Newswire

SN BioScience and Boryung Announce the Licensing Agreement on Generic Version of Abraxane PR Newswire

Drug maker Boryung targets its highest-ever sales in 2024 - The Korea Economic Daily Global Edition

Drug maker Boryung targets its highest-ever sales in 2024 The Korea Economic Daily Global Edition

Biotia Partners with Leading Korean Pharmaceutical Company to Advance Infectious Disease Diagnostics in Remote Regions -- Including in Space - PR Newswire

Biotia Partners with Leading Korean Pharmaceutical Company to Advance Infectious Disease Diagnostics in Remote Regions -- Including in Space PR Newswire

Boryung Holdings Launches a U.S. Subsidiary in San Francisco - Businesskorea

Boryung Holdings Launches a U.S. Subsidiary in San Francisco Businesskorea

Boryung shifts to sole CEO system, strengthening growth and space expansion - koreabiomed.com

Boryung shifts to sole CEO system, strengthening growth and space expansion koreabiomed.com

Eugene PE, KDB PE to acquire Boryung Biopharma for $231 million - The Korea Economic Daily Global Edition

Eugene PE, KDB PE to acquire Boryung Biopharma for $231 million The Korea Economic Daily Global Edition

Boryung, HK inno.N to co-market their flagship hypertension and GERD drugs - koreabiomed.com

Boryung, HK inno.N to co-market their flagship hypertension and GERD drugs koreabiomed.com

Dongwon solo bidder for Boryung Biopharma estimated at $385 mn - The Korea Economic Daily Global Edition

Dongwon solo bidder for Boryung Biopharma estimated at $385 mn The Korea Economic Daily Global Edition

Boryung and Bixink to co-market Nerlynx for HER2-positive breast cancer - koreabiomed.com

Boryung and Bixink to co-market Nerlynx for HER2-positive breast cancer koreabiomed.com

Boryung sings CDMO deal with Lotus Pharmaceutical to manufacture anticancer injection, expanding global reach - koreabiomed.com

Boryung sings CDMO deal with Lotus Pharmaceutical to manufacture anticancer injection, expanding global reach koreabiomed.com

Boryung’s cancer drug gets 'developmental orphan drug' designation - koreabiomed.com

Boryung’s cancer drug gets 'developmental orphan drug' designation koreabiomed.com

Boryung CEO charts bold future with space healthcare vision, reinforces pharma core - koreabiomed.com

Boryung CEO charts bold future with space healthcare vision, reinforces pharma core koreabiomed.com

Boryung Biopharma to supply MSD Korea’s pneumococcal vaccine - koreabiomed.com

Boryung Biopharma to supply MSD Korea’s pneumococcal vaccine koreabiomed.com

Boryung wins exclusive rights from Cheplapharm to sell anticancer drug Taxol in Korea - koreabiomed.com

Boryung wins exclusive rights from Cheplapharm to sell anticancer drug Taxol in Korea koreabiomed.com

How could Boryung triple its anticancer drug business in 4 years? - koreabiomed.com

How could Boryung triple its anticancer drug business in 4 years? koreabiomed.com

Boryung Biopharma establishes mRNA drug developer BPgene - koreabiomed.com

Boryung Biopharma establishes mRNA drug developer BPgene koreabiomed.com

Axiom Space Raises $350 Million in Latest Fundraising Round - Bloomberg.com

Axiom Space Raises $350 Million in Latest Fundraising Round Bloomberg.com

Boryung Consumer Healthcare launches 'Coenzyme Q10 Max' - koreabiomed.com

Boryung Consumer Healthcare launches 'Coenzyme Q10 Max' koreabiomed.com

Boryung to release new SCLC drug Zepzelca in March - koreabiomed.com

Boryung to release new SCLC drug Zepzelca in March koreabiomed.com

Boryung acquires Korean rights to Eli Lilly’s lung cancer drug - The Korea Herald

Boryung acquires Korean rights to Eli Lilly’s lung cancer drug The Korea Herald

Boryung releases hepatitis A vaccine proved effective on Koreans - koreabiomed.com

Boryung releases hepatitis A vaccine proved effective on Koreans koreabiomed.com

Boryung to launch spray-type hair loss treatment in Q1 of 2023 - koreabiomed.com

Boryung to launch spray-type hair loss treatment in Q1 of 2023 koreabiomed.com

Boryung Pharmaceutical Signs R&D Agreement with Vigencell to Develop Immunocyte Therapy - Businesskorea

Boryung Pharmaceutical Signs R&D Agreement with Vigencell to Develop Immunocyte Therapy Businesskorea

Boryung’s hair growth spray scores nod, challenging Propecia - koreabiomed.com

Boryung’s hair growth spray scores nod, challenging Propecia koreabiomed.com

Dongwon Group among companies bidding for Boryung Biopharma - 매일경제

Dongwon Group among companies bidding for Boryung Biopharma 매일경제

Boryung ties up with Baxter to expand anesthesiology business - koreabiomed.com

Boryung ties up with Baxter to expand anesthesiology business koreabiomed.com

Boryung finds cancer drug has antiviral effect on Covid-19 - koreabiomed.com

Boryung finds cancer drug has antiviral effect on Covid-19 koreabiomed.com

Boryung Pharmaceutical Secures Right for Exclusive Sale in Korea of World’s First Nano-micelle Cancer Treatment - Businesskorea

Boryung Pharmaceutical Secures Right for Exclusive Sale in Korea of World’s First Nano-micelle Cancer Treatment Businesskorea

Boryung signs deal with Stendhal to launch hypertension drug in Mexico - The Korea Economic Daily Global Edition

Boryung signs deal with Stendhal to launch hypertension drug in Mexico The Korea Economic Daily Global Edition

Pharmaceuticals seek fresh start with new CEOs - koreabiomed.com

Pharmaceuticals seek fresh start with new CEOs koreabiomed.com

Boryung sees strong uptake of hypertension drugs in Korean market - koreabiomed.com

Boryung sees strong uptake of hypertension drugs in Korean market koreabiomed.com

Boryung to sell antihypertensive drugs in SE Asia - koreabiomed.com

Boryung to sell antihypertensive drugs in SE Asia koreabiomed.com

Boryung Pharmaceutical Acquires Zyprexa, schizophrenia Drug from Eli Lilly - newsworld.co.kr

Boryung Pharmaceutical Acquires Zyprexa, schizophrenia Drug from Eli Lilly newsworld.co.kr

[Space Bud] ⑭ From Powder to Pill: A Visit to Boryung's Yesan Campus - 동아사이언스

[Space Bud] ⑭ From Powder to Pill: A Visit to Boryung's Yesan Campus 동아사이언스

Korean Pharmaceutical Companies Complaining about Gov't Drug Price Control - Businesskorea

Korean Pharmaceutical Companies Complaining about Gov't Drug Price Control Businesskorea

Boryung’s Kanarbⓡ Enters Central, South American Markets - newsworld.co.kr

Boryung’s Kanarbⓡ Enters Central, South American Markets newsworld.co.kr

Yonggaksan Cool Turns out to be Effective in Removing Phlegm - newsworld.co.kr

Yonggaksan Cool Turns out to be Effective in Removing Phlegm newsworld.co.kr

[Park Soo-nam’s CEO Analysis 2] Boryung Chairman Kim Jung-kyun – The Flashy Shell of a Third-Generation Owner, Hollow Management Philosophy… Stock Price Plummets as Core Business Drifts - CEONEWS

[Park Soo-nam’s CEO Analysis 2] Boryung Chairman Kim Jung-kyun – The Flashy Shell of a Third-Generation Owner, Hollow Management Philosophy… Stock Price Plummets as Core Business Drifts CEONEWS

Boryung Returns to Lead Tarceva Sales in Korea After 5 Years - 히트뉴스

Boryung Returns to Lead Tarceva Sales in Korea After 5 Years 히트뉴스

The result of pre-clinical trial of ‘PI3K·DNA-PK inhibiting anti-cancer drug’ from Boryung Pharmaceutical - 바이오스펙테이터

The result of pre-clinical trial of ‘PI3K·DNA-PK inhibiting anti-cancer drug’ from Boryung Pharmaceutical 바이오스펙테이터

Boryung CEO Jang: ‘Anticancer Drive’ to Boost Revenue in 2024 - 히트뉴스

Boryung CEO Jang: ‘Anticancer Drive’ to Boost Revenue in 2024 히트뉴스

Boryung Pharma’s Sales Skyrocket to $311mn in H1 2023 - 히트뉴스

Boryung Pharma’s Sales Skyrocket to $311mn in H1 2023 히트뉴스

Boryung’s Trudapa Tops Generic Market for Dapagliflozin in Diabetes Treatment - 히트뉴스

Boryung’s Trudapa Tops Generic Market for Dapagliflozin in Diabetes Treatment 히트뉴스

Samsung Bioepis Deepens Local Ties to Drive Dual Biosimilar Strategy - 히트뉴스

Samsung Bioepis Deepens Local Ties to Drive Dual Biosimilar Strategy 히트뉴스

Top Boryung Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant